Gyre Therapeutics (GYRE) Assets (2010 - 2026)
Gyre Therapeutics' Assets came in at $199.26 million for Q2 2026, up 30.5% from $152.65 million a year earlier and up 23.0% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Assets was $219.76 million, up 75.2% from FY2024.
- Assets has increased in each of the last four years, with a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- Going back by year, Assets was $125.41 million in FY2024 (+7.6%), $116.54 million in FY2023 (+37.5%), $84.75 million in FY2022 (+52.3%) and $55.66 million in FY2021 (-41.3%).
- The five-year range for quarterly Assets is $9.96 million (Q3 2023) to $219.76 million (Q4 2025).
- Year-over-year, Assets has increased for seven consecutive quarters, with growth averaging 28.3% over the last seven quarters.
- The fastest year-over-year change in Assets over five years came in Q2 2024 (growth of 875.7%), and the weakest in Q2 2023 (a decline of 85.1%).
- Business Quant data shows GYRE's Assets at $162.02 million (Q1 2026), $219.76 million (Q4 2025) and $159.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 199.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199.26 Mn |
| Mar 31, 2026 | 162.02 Mn |
| Dec 31, 2025 | 219.76 Mn |
| Sep 30, 2025 | 159.38 Mn |
| Jun 30, 2025 | 152.65 Mn |
| Mar 31, 2025 | 129.79 Mn |
| Dec 31, 2024 | 125.41 Mn |
| Sep 30, 2024 | 125.24 Mn |
| Jun 30, 2024 | 120.93 Mn |
| Mar 31, 2024 | 122.01 Mn |
| Dec 31, 2023 | 116.54 Mn |
| Sep 30, 2023 | 9.96 Mn |
| Jun 30, 2023 | 12.39 Mn |
| Mar 31, 2023 | 18.75 Mn |
| Dec 31, 2022 | 84.75 Mn |
| Sep 30, 2022 | 31.02 Mn |
| Jun 30, 2022 | 83.37 Mn |
| Mar 31, 2022 | 40.27 Mn |
| Dec 31, 2021 | 55.66 Mn |
| Sep 30, 2021 | 78.54 Mn |
API Access
Gyre Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();